GLP-1 receptor agonist exerts its action through the GLP-1R
Reduce barrier permeability and enhance barrier tightness Caco-2 cells are a type of human colon adenocarcinoma cell that can differentiate into polar columnar epithelial cells when cultured in vitro, forming tight junction structures similar to those in vivo
They're receptive, attentive, and extremely helpful
This multi-receptor approach distinguishes it from existing licensed medicines such as semaglutide (Ozempic, Wegovy) or tirzepatide licensed in the UK as Mounjaro for type 2 diabetes and as Zepbound for obesity which act on fewer receptor pathways
Engaging with GLP-1 users on platforms like TikTok and Instagram likely helps increase treatment awareness among younger adults, while also providing a positive example of what their own journey could look like
The quiet phase is a normal period of reduced visible change that often follows the initial adjustment phase of GLP-1 treatment